Stay updated on Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    Change Detected
    Summary
    The study has expanded to 147 locations and has been updated to revision v2.10.0, replacing the previous revision v2.9.7.
    Difference
    0.3%
    Check dated 2024-07-22T15:05:55.000Z thumbnail image
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T10:44:45.000Z thumbnail image
  7. Check
    23 days ago
    Change Detected
    Summary
    An erratum has been added to the article regarding Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment, published in Lancet in 2017.
    Difference
    0.1%
    Check dated 2024-07-03T21:51:51.000Z thumbnail image
  8. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-07-01T18:27:15.000Z thumbnail image
  9. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.4 to v2.9.5, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-06-27T15:22:39.000Z thumbnail image
  10. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.4, indicating a recent revision in the content of the web page.
    Difference
    0.1%
    Check dated 2024-06-26T15:11:22.000Z thumbnail image

Stay in the know with updates to Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.